You are viewing the site in preview mode
Skip to main content
| |
Overall
|
Center A
|
Center B
|
p value
|
|---|
|
Screening completeness
| | | | |
|
HPV-negative women, the results given
|
247/249 (99.2)
|
127/128 (99.2)
|
120/121 (99.2)
|
1
|
|
HPV-positive women, VIA done and negative
|
49/55 (89.1)
|
21/25 (84.0)
|
28/30 (93.3)
|
0.56
|
|
HPV-positive women, VIA positive and treatment provided
|
3/6 (50.0)
|
2/4 (50.0)
|
1/2 (50.0)
|
1
|
|
Women with complete screening sequencea
|
299/317 (94.3)
|
150/160 (93.8)
|
149/157 (94.9)
|
0.84
|
|
Women satisfaction (high vs low)b
| | | | |
|
Postsampling
|
205/317 (64.7)
|
128/160 (80.0)
|
77/157 (49.0)
|
< 0.001
|
|
Postresults
|
300/315 (94.6)
|
146/158 (91.2)
|
154/157 (98.1)
|
0.014
|
|
Post-VIA
|
38/55 (69.1)
|
15/25 (60.0)
|
23/30 (76.7)
|
0.29
|
- Data are number of women (%)
- aScreening sequence was considered complete when an HPV-negative woman was informed of the result of the HPV test, when an HPV-positive woman had a subsequent negative VIA test, or when an HPV-positive woman with a subsequent positive VIA test had an appropriate treatment
- bSatisfaction was assessed at three steps: after vaginal sampling (postsampling); after women received their test results (postresults); and after the visual inspection if relevant (post-VIA)
